Fiera Capital Corp Baxter International Inc Transaction History

Fiera Capital Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$49.7 - $57.71 $58,447 - $67,866	-1,176 Reduced 11.89%	8,714 $444,000
Q3 2022 Nov 03, 2022	SELL	$53.86 - $66.8 $1.34 Million - $1.66 Million	-24,819 Reduced 71.51%	9,890 $530,000
Q2 2022 Aug 10, 2022	BUY	$63.83 - $80.0 $133,213 - $166,960	2,087 Added 6.4%	34,709 $2.23 Million
Q1 2022 May 09, 2022	SELL	$76.85 - $89.45 $481,234 - $560,135	-6,262 Reduced 16.1%	32,622 $2.53 Million
Q4 2021 Feb 08, 2022	BUY	$74.57 - $87.19 $488,433 - $571,094	6,550 Added 20.26%	38,884 $3.34 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $394,595 - $447,229	5,349 Added 19.82%	32,334 $2.6 Million
Q2 2021 Aug 11, 2021	BUY	$80.5 - $88.01 $1.86 Million - $2.03 Million	23,049 Added 585.59%	26,985 $2.32 Million
Q1 2021 May 11, 2021	BUY	$76.38 - $86.03 $300,631 - $338,614	3,936 New	3,936 $332,000
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $217,745 - $240,161	-2,675 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$73.44 - $82.41 $196,452 - $220,446	2,675 New	2,675 $219,000

989

448M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.